FUSE Health vs. Amazon: GLP-1 Infrastructure Comparison

GLP-1 program vs marketplace dispensing: how pharmacy systems with telehealth integration differ on compliance posture, patient LTV, and operator margin.

Features And Capabilities	Fuse	Amazon
HIPAA-Compliant Infrastructure	yes	no
Operator White Label Platform	yes	no
Clinical Intake and Review Workflows	yes	no
Provider Network Pre-configured	yes	no
GLP-1 Pharmacy Routing	yes	no
LegitScript Certified	yes	no
GLP-1 Pharmacy Routing	yes	no
GLP-1 Pharmacy Routing	yes	no

Amazon Pharmacy Fills. FUSE Builds Programs.

Amazon sells medications through Amazon Pharmacy but does not provide the infrastructure to build a telehealth program. FUSE gives operators everything needed to launch a GLP-1 or semaglutide revenue channel — clinical intake, provider review, pharmacy routing, and subscription billing — under their own brand. LegitScript is the certification body that Google and Meta require before approving paid advertising for telehealth programs. Without LegitScript certification, GLP-1 programs cannot run paid acquisition on the two largest digital ad platforms. Obtaining LegitScript independently takes 60 to 90 days and requires extensive documentation. FUSE is LegitScript certified — operators on the FUSE platform can run paid ads from day one.

Operator storefront from day on

Your brand, your checkout, your customer relationship. FUSE runs the clinical and compliance layer behind the scenes. Patients experience the operator brand at every touchpoint. Patient data and relationships belong to the operator, not a marketplace.

Prescription routing pre-built

GLP-1 and semaglutide prescriptions route to configured pharmacy partners automatically from the first patient interaction. Operators do not manage pharmacy contracts. Amazon Pharmacy does not dispense compounded semaglutide — for operators who need compounded formulations, FUSE connects to compounding pharmacy partners.

No marketplace dependency

Amazon's pharmacy and healthcare model benefits Amazon. Patient relationships, data, and purchasing behavior accrue to the Amazon platform. FUSE operators control the patient relationship from intake through refill. The storefront, data, subscription, and brand equity belong to the operator.

Selling GLP-1 Requires More Than a Marketplace Listing

Amazon Pharmacy is a fulfilment endpoint. Operators who want to build a GLP-1 program need intake infrastructure, a provider network, clinical review workflows, and compliance structure — none of which a marketplace provides. Clinical review is not optional. GLP-1 programs require provider oversight. FUSE pre-configures provider networks so operators do not build clinical staffing from scratch

Clinical review is not optional

GLP-1 programs require licensed provider oversight for every prescription. FUSE pre-configures provider networks across multiple states so operators do not hire, credential, or manage physicians independently. Amazon Pharmacy dispenses — it does not provide the clinical review layer

LegitScript certification matters

Without LegitScript, operators cannot run paid ads for GLP-1 programs on Google or Meta. FUSE is certified. Operators on the FUSE platform can run paid acquisition from day one without a separate 60 to 90 day certification process.

A Fundamentally Different Scheduling Experience.

	With FUSE	With Amazon
Customer ownership	FUSE operators own their storefront, patient data, and customer relationships. Patients build loyalty with the operator brand. Revenue flows to the operator.	Amazon owns the customer relationship for Amazon Pharmacy and One Medical patients. Operators using marketplace models build on rented ground.
Clinical workflows	FUSE includes intake, provider review, prescription routing, and refill logic as a single coordinated system. All components are pre-configured for GLP-1 and semaglutide programs	Amazon Pharmacy handles dispensing only. Clinical intake, provider review, and refill logic must be built and managed independently by operators
Compliance structure	FUSE is LegitScript certified and includes BAA coverage across the full clinical workflow from day one. Paid acquisition channels are available from the first patient.	Marketplace and pharmacy models do not provide the compliance infrastructure operators need to run a regulated telehealth program or access paid advertising channels.
Revenue model	Subscription and refill logic generates recurring revenue from the first patient forward. Programs compound over time without additional acquisition spend per refill cycle	Amazon Pharmacy transactions are episodic. Recurring revenue requires a separate program layer that Amazon does not provide for independent operators.

Daniel Meursing

CEO

Daniel is a two-time founder who has scaled service businesses across major U.S. markets. A Y Combinator competition winner, he focuses on removing operational and regulatory barriers so operators can build and scale modern healthcare businesses.

Background: Startup Operations & Service Systems
Experience: 2x Founder, Multi-Market U.S. Scaling
Qualifications: Healthtech Market Expertise & Operational Scaling
Key Achievement: Scaled Premier Staff & Eventstaff across major U.S. markets

Frequently Asked Questions

Can I run paid ads immediately?

Yes. FUSE is LegitScript certified from day one, enabling immediate paid campaigns on Google and Meta. Amazon Pharmacy cannot provide this—operators face a mandatory 60-90 day certification delay before accessing paid advertising channels.

Do I own my customer data?

Completely. FUSE operators own storefronts, patient data, and relationships. Patients build loyalty with your brand. With Amazon Pharmacy, the platform owns all relationships; you're a vendor on someone else's marketplace, not a business owner.

What's included in FUSE's clinical infrastructure?

FUSE pre-configures provider networks, intake workflows, clinical review, prescription routing, and refill logic as one integrated system. All compliance layers are built in and LegitScript-certified. This pre-configuration eliminates months of independent setup and clinical staffing.

Can I offer compounded medications?

Yes. FUSE routes prescriptions to compounding pharmacy partners automatically. Your patients access compounded semaglutide and other formulations seamlessly. This flexibility supports diverse operator needs and patient preferences without manual pharmacy management.

How does recurring revenue work with FUSE?

FUSE's native subscription and refill logic generates recurring revenue from patient one; revenue compounds without additional acquisition spend per cycle. This creates a sustainable business model that rewards retention over constant new patient acquisition.

Fuse vs Amazon